Proton radiation aimed away from the brain for cancer that has spread to the fluid around the brain and spine
Official title: BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study tests a form of proton radiation for adults whose solid tumor cancer has spread to the lining of the brain and spine.
Read our full plain-language summary
What the trial team says
The purpose of this study is to determine the efficacy of BRain-AVOidant proton craniospinal irradiation (BRAVO pCSI) in adult participants with leptomeningeal metastases from solid tumors.
Key facts
- Registry number
- NCT07789912
- Stage of testing
- Phase 2
- Conditions studied
- Leptomeningeal Metastasis, Breast Cancer, Lung Cancer (NSCLC)
Where it is running
This trial lists 1 site.
-
Florida
- University of Miami (Miami)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.